REQUEST A DEMO
Total
USD $0.00
Search more companies

Neuca Clinical Trials Investments Sp. z o.o. (Poland)

Main Activities: All Other Nondepository Credit Intermediation
Secondary Activities: Other Activities Related to Credit Intermediation | Lessors of Real Estate | Office Machinery and Equipment Rental and Leasing | Office Administrative Services | Convention and Trade Show Organizers | All Other Support Services
Full name: Neuca Clinical Trials Investments Sp. z o.o. Profile Updated: April 01, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Neuca Clinical Trials Investments Sp. z o.o. is an enterprise based in Poland. Its main office is in Torun. It operates in the All Other Nondepository Credit Intermediation industry. It was incorporated on August 02, 2001. It currently has a total number of 1 - 5 (2014) employees. A negative growth of 8.17% was recorded in its total assets.

Headquarters
Ul. Forteczna 35-37
Torun; Kujawsko-Pomorskie; Postal Code: 87-100

Contact Details: Purchase the Neuca Clinical Trials Investments Sp. z o.o. report to view the information.

Website: http://www.apofarm.pl

Basic Information
Total Employees:
Purchase the Neuca Clinical Trials Investments Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Neuca Clinical Trials Investments Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Neuca Clinical Trials Investments Sp. z o.o. report to view the information.
Incorporation Date:
August 02, 2001
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Martinique Investment Sp. z o.o.
100%
Company Performance
Financial values in the chart are available after Neuca Clinical Trials Investments Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total Operating Revenue
-70.35%
Operating Profit
25.18%
EBITDA
25.18%
Net Profit/Loss for the Period
-54.61%
Total Assets
-8.17%
Total Equity
-8.14%
Return on Equity (ROE)
-7.54%
Quick Ratio
33.53%
Cash Ratio
0.75%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?